Robert Weinberg

Q: What Schools Are Affiliated With Robert Weinberg

Robert Weinberg is affiliated with the following schools: Yale University, Weizmann Institute of Science, Massachusetts Institute of Technology, Harvard University, University of Pennsylvania

Robert Weinberg 's AcademicInfluence.com Rankings

Robert Weinberg

Biology

#117

World Rank

#211

Historical Rank

#68

USA Rank

Molecular Biology

#18

World Rank

#18

Historical Rank

#10

USA Rank

biology Degrees

Download Badge

Biology

Robert Weinberg 's Degrees

Bachelors Biology University of Pennsylvania

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Robert Weinberg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Allan Weinberg is a biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology , director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.

(See a Problem?)

Robert Weinberg 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hallmarks of Cancer: The Next Generation (2011) (45671)
The Hallmarks of Cancer (2000) (29017)
The basics of epithelial-mesenchymal transition. (2009) (8435)
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells (2008) (8195)
The retinoblastoma protein and cell cycle control (1995) (5111)
A Perspective on Cancer Cell Metastasis (2011) (3945)
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis (2004) (3762)
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion (2005) (3515)
Tumor Metastasis: Molecular Insights and Evolving Paradigms (2011) (3204)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits (2009) (3183)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis (2007) (3008)
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. (2008) (2951)
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma (1986) (2880)
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes (1983) (2699)
Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) (2583)
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase (2001) (2479)
Creation of human tumour cells with defined genetic elements (1999) (2418)
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors (2008) (2387)
The Biology of Cancer (1957) (2297)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening (2009) (2280)
Tumor spectrum analysis in p53-mutant mice (1994) (2115)
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (2007) (1962)
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization (1997) (1879)
Effects of an Rb mutation in the mouse (1992) (1877)
Emerging Biological Principles of Metastasis (2017) (1867)
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer (2018) (1777)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications (2017) (1592)
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product (1988) (1451)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. (2008) (1431)
Ras oncogenes: split personalities (2008) (1351)
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis (2010) (1316)
Lentivirus-delivered stable gene silencing by RNAi in primary cells. (2003) (1266)
EMT in cancer (2018) (1244)
Mechanism of activation of a human oncogene (1982) (1244)
Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation (1993) (1174)
Tumor suppressor genes. (1991) (1166)
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen (1984) (1139)
Cellular oncogenes and multistep carcinogenesis. (1983) (1100)
Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes (1998) (1098)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state (2011) (1095)
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins (1992) (1095)
Cyclin D1 provides a link between development and oncogenesis in the retina and breast (1995) (1092)
The neu oncogene encodes an epidermal growth factor receptor-related protein (1986) (1074)
Inhibition of telomerase limits the growth of human cancer cells (1999) (1051)
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase (1992) (1042)
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. (1989) (1026)
The signals and pathways activating cellular senescence. (2005) (1007)
Modelling the molecular circuitry of cancer (2002) (1007)
The epigenetics of epithelial-mesenchymal plasticity in cancer (2013) (1001)
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 (1986) (994)
Cancer stem cells: mirage or reality? (2009) (984)
Rules for making human tumor cells. (2002) (966)
Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics (2000) (956)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes (2010) (932)
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. (2001) (908)
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene (1982) (861)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast (2011) (846)
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State (2012) (834)
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. (2012) (820)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. (2015) (811)
Tackling the cancer stem cells — what challenges do they pose? (2014) (809)
Reconstruction of functionally normal and malignant human breast tissues in mice. (2004) (803)
Physical interaction of the retinoblastoma protein with human D cyclins (1993) (794)
Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene (1997) (787)
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts (1981) (787)
Suppression of intestinal neoplasia by DNA hypomethylation (1995) (781)
Guidelines and definitions for research on epithelial–mesenchymal transition (2020) (778)
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type (2006) (775)
Telomerase Maintains Telomere Structure in Normal Human Cells (2003) (752)
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation (1984) (751)
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 (1994) (747)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model (2010) (737)
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (2008) (735)
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis (1996) (733)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity (2013) (729)
Isolation of a transforming sequence from a human bladder carcinoma cell line (1982) (723)
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts (2010) (705)
The action of oncogenes in the cytoplasm and nucleus. (1985) (690)
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis (2014) (690)
A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (2009) (683)
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation (2002) (657)
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. (1998) (656)
Expression cloning and characterization of the TGF-β type III receptor (1991) (617)
EMT, cell plasticity and metastasis (2016) (590)
Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. (2001) (585)
Comparative biology of mouse versus human cells: modelling human cancer in mice (2003) (579)
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers (2007) (577)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells (2015) (577)
Species- and cell type-specific requirements for cellular transformation. (2004) (572)
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. (1990) (557)
The pathway to signal achievement (1993) (555)
The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. (1985) (533)
Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. (2000) (508)
Function of a human cyclin gene as an oncogene. (1994) (493)
A progression puzzle. (2002) (481)
A paracrine role for the epithelial progesterone receptor in mammary gland development. (1998) (475)
Shared role of the pRB-related p130 and p107 proteins in limb development. (1996) (470)
Growth suppression by p16ink4 requires functional retinoblastoma protein. (1995) (465)
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. (1979) (451)
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation (2005) (448)
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism (2002) (445)
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase (1998) (440)
Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression (2008) (426)
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. (1996) (422)
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin (2008) (421)
Small molecular weight monodisperse nuclear RNA. (1968) (418)
Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness (2015) (416)
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies (1985) (414)
Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. (1987) (411)
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues (1998) (404)
Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression (1986) (403)
Point mutational inactivation of the retinoblastoma antioncogene. (1989) (397)
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation (2001) (393)
Metastasis genes: A progression puzzle (2002) (388)
When cells get stressed: an integrative view of cellular senescence. (2004) (388)
Association of Cdk-activating kinase subunits with transcription factor TFIIH (1995) (382)
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities (2018) (380)
How cancer arises. (1996) (376)
Basic fibroblast growth factor fused to a signal peptide transforms cells (1988) (372)
Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. (1997) (368)
Rescue of Cyclin D1 Deficiency by Knockin Cyclin E (1999) (364)
Prolactin controls mammary gland development via direct and indirect mechanisms. (1999) (360)
Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. (2003) (353)
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages (2014) (350)
Telomeres: cancer to human aging. (2006) (349)
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. (1995) (345)
Erosion of the telomeric single-strand overhang at replicative senescence (2003) (336)
Cell cycle-specific association of E2F with the p130 E1A-binding protein. (1993) (333)
Cell plasticity and heterogeneity in cancer. (2013) (326)
Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. (1994) (323)
The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors (1983) (322)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. (2016) (319)
Molecular cloning of cDNAs encoding the GAP-associated protein p190: Implications for a signaling pathway from ras to the nucleus (1992) (317)
Taking the Study of Cancer Cell Survival to a New Dimension (2002) (313)
Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. (2007) (312)
Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs (2009) (311)
A molecular basis of cancer. (1983) (311)
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts (1996) (311)
Exploring a new twist on tumor metastasis. (2006) (309)
G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment (1991) (307)
Genes involved in senescence and immortalization. (2000) (306)
Association between GTPase activators for Rho and Ras families (1992) (303)
Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion. (1988) (303)
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity (1986) (299)
Tumor suppressor genes (1993) (297)
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells (2019) (295)
Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. (1994) (293)
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. (2012) (290)
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (2009) (287)
Cell-cycle control and its watchman (1996) (280)
Tumor-host interactions: a far-reaching relationship. (2010) (280)
Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution (1997) (279)
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. (1999) (276)
A cyclin associated with the CDK-activating kinase MO15 (1994) (272)
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. (2013) (269)
N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma (1986) (267)
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts (1986) (265)
The restriction point and control of cell proliferation. (1997) (263)
Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling (1999) (260)
Plasticity of ether lipids promotes ferroptosis susceptibility and evasion (2020) (258)
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy (2018) (256)
Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. (1993) (251)
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability (2016) (250)
The catalytic subunit of yeast telomerase. (1997) (250)
Immortalization and transformation of primary human airway epithelial cells by gene transfer (2002) (248)
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. (1998) (246)
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas (1982) (246)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer (2010) (246)
Upholding a role for EMT in breast cancer metastasis (2017) (241)
Coming Full Circle—From Endless Complexity to Simplicity and Back Again (2014) (241)
Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos (2003) (239)
Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. (2017) (234)
E2F and Cell Proliferation: A World Turned Upside Down (1996) (233)
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. (1986) (232)
The Spemann organizer gene, Goosecoid, promotes tumor metastasis (2006) (224)
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells (2017) (222)
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters (1985) (214)
DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. (1981) (213)
Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. (1988) (212)
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells? (2011) (210)
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. (2011) (208)
Three different human tumor cell lines contain different oncogenes (1981) (208)
Requirement for TFIIH kinase activity in transcription by RNA polymerase II (1995) (204)
The retinoblastoma protein and the regulation of cell cycling. (1992) (201)
Control of the cell cycle and apoptosis. (1999) (200)
Processing of 45 s nucleolar RNA. (1970) (200)
The integrated genome of murine leukemia virus (1978) (198)
Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: Enhancement of the gag-pol polypeptide with yeast suppressor tRNA (1978) (197)
Characterization of a human colon/lung carcinoma oncogene (1983) (197)
Oncogenes and the molecular origins of cancer (1989) (196)
Oncogenes and tumor-suppressing genes. (1988) (195)
Upholding a role for EMT in pancreatic cancer metastasis (2017) (194)
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. (1991) (193)
Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. (2007) (193)
A mouse model of human breast cancer metastasis to human bone. (2005) (192)
Micromanagers of malignancy: role of microRNAs in regulating metastasis. (2008) (190)
The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. (2012) (190)
The basics of epithelial-mesenchymal transition (The Journal of Clinical Investigation (2009) 119, 6, (1420-1428) DOI: 10.1172/JCI39104) (2010) (190)
EMT and Cancer: More Than Meets the Eye. (2019) (190)
Methylation of the human telomerase gene CpG island. (2000) (188)
Ski/Sno and TGF-β signaling (2001) (186)
Acrylamide gel electrophoresis of HeLa cell nucleolar RNA. (1967) (183)
Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes (1981) (183)
IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. (2002) (182)
THE SELECTIVE INTERRUPTION OF NUCLEOLAR RNA SYNTHESIS IN HELA CELLS BY CORDYCEPIN (1969) (181)
Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition (2014) (179)
Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. (2007) (171)
Mechanisms of malignant progression. (2008) (170)
Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence (2009) (167)
Linking EMT programmes to normal and neoplastic epithelial stem cells (2021) (166)
An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. (2013) (166)
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells (2017) (162)
The role of RB in cell cycle control. (1995) (158)
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. (2000) (156)
Serum Response Factor Is Required for Immediate-Early Gene Activation yet Is Dispensable for Proliferation of Embryonic Stem Cells (2001) (155)
A checkpoint on the road to cancer (1998) (151)
Generation of mammalian cells stably expressing multiple genes at predetermined levels. (2000) (149)
Oncogenes of spontaneous and chemically induced tumors. (1982) (149)
Telomerase and human tumorigenesis. (2000) (147)
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene (1984) (146)
The Cat and Mouse Games That Genes, Viruses, and Cells Play (1997) (145)
Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor (1986) (144)
Adaptation versus selection: the origins of metastatic behavior. (2007) (144)
Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene (1982) (140)
MicroRNAs in malignant progression (2008) (140)
Derivation of human tumor cells in vitro without widespread genomic instability. (2001) (140)
A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection (1979) (139)
The Molecular Basis of Oncogenes and Tumor Suppressor Genes (1995) (136)
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. (1986) (134)
Expression cloning and characterization of the TGF-beta type III receptor. (1991) (133)
How does multistep tumorigenesis really proceed? (2015) (130)
Journey to the Center of Biology (2000) (129)
Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. (1987) (129)
Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. (2011) (128)
Chemokine networks and breast cancer metastasis. (2006) (128)
miR-31: A crucial overseer of tumor metastasis and other emerging roles (2010) (126)
Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. (1995) (124)
Control of the cell cycle and apoptosis. (1999) (124)
A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. (1995) (124)
AIB1 enhances estrogen-dependent induction of cyclin D1 expression. (2001) (123)
A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. (1995) (123)
LACTB is a tumour suppressor that modulates lipid metabolism and cell state (2017) (121)
Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. (2009) (120)
Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. (2010) (118)
c‐myc and c‐fos expression in differentiating mouse primary keratinocytes. (1986) (118)
Oncogenes and tumor suppressor genes (1988) (116)
Heterogeneity of stromal fibroblasts in tumor (2007) (116)
The Expanding Role of Cell Cycle Regulators (1998) (111)
Genes and the Biology of Cancer (1992) (110)
Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. (1987) (110)
Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence (2011) (109)
Tumor suppressor genes. (1994) (109)
Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency. (2016) (109)
Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene (1984) (108)
Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts. (1996) (108)
Metabolism of small molecular weight monodisperse nuclear RNA. (1969) (107)
Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. (1985) (107)
Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. (1988) (105)
Identification of a nucleotide exchange-promoting activity for p21ras. (1990) (105)
Identification of DNA fragments carrying ecotropic proviruses of AKR mice. (1979) (102)
Slug and Sox 9 Cooperatively Determine the Mammary Stem Cell State Citation (101)
Activation of miR-31 function in already-established metastases elicits metastatic regression. (2011) (101)
Emerging Mechanisms by which EMT Programs Control Stemness. (2020) (100)
The molecules of life. (1985) (100)
Characterization and expression of the human rhoH12 gene product (1989) (100)
IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization (2018) (99)
Ski/Sno and TGF-beta signaling. (2001) (99)
Roles for microRNAs in the regulation of cell adhesion molecules (2011) (98)
Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAS: Discovery of a smaller circular form (1979) (97)
Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene. (1989) (97)
Oncogene from human EJ bladder carcinoma is located on the short arm of chromosome 11. (1983) (96)
Point: Hypotheses first (2010) (95)
EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling (2017) (94)
The evolving portrait of cancer metastasis. (2005) (94)
Heterogeneity of stromal fibroblasts in tumors. (2007) (93)
DNA methylation affecting the expression of murine leukemia proviruses (1982) (92)
Coevolution in the tumor microenvironment (2008) (92)
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. (1975) (91)
Twisted epithelial–mesenchymal transition blocks senescence (2008) (91)
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. (1996) (89)
Unique transforming gene in carcinogen-transformed mouse cells (1981) (87)
One Renegade Cell: How Cancer Begins (1998) (87)
Senescence: does it all happen at the ends? (2002) (86)
Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. (1997) (85)
MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis (2009) (84)
AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. (2010) (84)
Isolation and Characterization of Simian Virus 40 Ribonucleic Acid (1972) (84)
The retinoblastoma gene and cell growth control. (1990) (82)
Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. (1999) (81)
Cooperative Binding of Transforming Growth Factor (TGF)-β2 to the Types I and II TGF-β Receptors (*) (1995) (79)
Genomics: journey to the center of biology. (2000) (79)
Dependence of Moloney murine leukemia virus production on cell growth. (1975) (78)
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade (2019) (77)
The Epithelial-Mesenchymal Transition Factor SNAIL Paradoxically Enhances Reprogramming (2014) (76)
Fewer and fewer oncogenes (1982) (75)
Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination (1981) (74)
In vitro synthesis of infectious DNA of murine leukaemia virus (1977) (72)
Evidence for the Asiatic origin of endogenous AKR-type murine leukemia proviruses (1980) (70)
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer (2018) (69)
Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene (1983) (68)
A Specific Role for Cyclin D1 in Mammary Gland Development (1997) (68)
Human c-Ki-ras2 proto-oncogene on chromosome 12. (1983) (67)
Infectious viral DNA of murine leukemia virus. (1975) (65)
Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization (2000) (65)
Continuing germ line integration of AKV proviruses during the breeding of AKR mice and derivative recombinant inbred strains (1982) (65)
Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. (1996) (64)
The Hallmarks of Cancer Review (2000) (62)
An interaction between p21ras and heat shock protein hsp60, a chaperonin. (1992) (62)
Leaving home early: reexamination of the canonical models of tumor progression. (2008) (61)
Finding the anti-oncogene. (1988) (60)
Mechanism of induction of RNA tumor viruses by halogenated pyrimidines. (1975) (57)
p21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect. (1988) (55)
The N-terminal and C-terminal domains of a receptor tyrosine phosphatase are associated by non-covalent linkage. (1992) (54)
Partially single-stranded form of free Moloney viral DNA (1975) (53)
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy (2017) (52)
Simian Virus 40 Transcription in Productively Infected and Transformed Cells (1974) (48)
Comparative study of different isolates of murine sarcoma virus (1979) (47)
High efficiency creation of human monoclonal antibody-producing hybridomas. (2004) (47)
The retinoblastoma gene and gene product. (1992) (47)
Guidance of developing axons by netrin-1 and its receptors. (1997) (47)
Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling (2018) (47)
Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer (1997) (46)
Distinct RNA Synthesis Systems of the HeLa Cell (1970) (44)
Positive and negative controls on cell growth. (1989) (44)
Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. (2020) (42)
Unusual metabolism of 5 S RNA in HeLa cells. (1973) (41)
Direct and Indirect Regulators of Epithelial-Mesenchymal Transition (EMT)-mediated Immunosuppression in Breast Carcinomas. (2020) (41)
ras Oncogenes and the molecular mechanisms of carcinogenesis. (1984) (41)
Tossing monkey wrenches into the clock: new ways of treating cancer. (1999) (40)
Identification of a protein associated with p21ras by chemical crosslinking. (1989) (40)
The integration of molecular genetics into cancer management (1992) (38)
The genetic origins of human cancer (1988) (36)
Genetic sequences that predispose to retinoblastoma and osteosarcoma. (1986) (35)
Ma et al. reply (2008) (34)
The Rb gene and the negative regulation of cell growth. (1989) (34)
The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium (2002) (34)
The molecular basis of carcinogenesis: understanding the cell cycle clock. (1996) (33)
Telomeres: Bumps on the road to immortality (1998) (33)
Poly A associated with SV40 messenger RNA. (1972) (31)
Proviral DNA of Moloney leukemia virus: purification and visualization. (1976) (30)
Translational Cancer Research (2009) (30)
A Lost Generation (2006) (30)
Origins and roles of endogenous retroviruses (1980) (30)
Biological Hallmarks of Cancer (2017) (29)
Cancer cell of origin: spotlight on luminal progenitors. (2010) (29)
Activation of Ha-ras p21 by substitution, deletion, and insertion mutations (1985) (28)
Analysis of viral and somatic activations of the cHa-ras gene (1985) (27)
RAS is required for epidermal growth factor-stimulated arachidonic acid release in rat-1 fibroblasts. (1993) (27)
Physical map of biologically active Harvey sarcoma virus unintegrated linear DNA (1979) (27)
Construction and use of a dominant, selectable marker: a Harvey sarcoma virus-dihydrofolate reductase chimera. (1983) (26)
An MSV-specific subgenomic mRNA in MSV-transformed G8-124 cells (1979) (26)
Of mice and (wo)men: Mouse models of breast cancer metastasis to bone (2010) (26)
Poised with purpose: Cell plasticity enhances tumorigenicity (2013) (26)
Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells (2014) (25)
Characterization of tumors produced by signal peptide‐basic fibroblast growth factor‐transformed cells (1989) (24)
Correction for Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs, by Tsukasa Shibue and Robert A. Weinberg, which (2009) (24)
Functional genomics and the breast cancer problem. (2002) (24)
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer (2020) (23)
Oncogenes and the molecular biology of cancer (1983) (23)
Alteration of the genomes of tumor cells (1983) (23)
The many faces of tumor dormancy. (2008) (22)
Modulation of retinoblastoma protein activity during the cell cycle. (1991) (22)
Structure of the provirus within NIH 3T3 cells transfected with Harvey sarcoma virus DNA (1981) (21)
Infectious, linear, unintegrated DNA of Moloney murine leukemia virus (1976) (21)
Eighteenth annual pezcoller symposium: tumor microenvironment and heterotypic interactions. (2006) (20)
The cancer cell and the cell cycle clock. (1994) (19)
Racing to the Beginning of the Road: The Search for the Origin of Cancer (1996) (19)
The many faces of tumor dormancy (2008) (19)
Erratum: Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudinlow and metaplastic breast cancer subtypes (Proceedings of the National Academy of Sciences of the United States of America (2010) 107:35 (15449-15454)) (2010) (18)
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis (2022) (17)
Scientific American molecular oncology (1996) (16)
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. (2020) (16)
Prospects for cancer genetics. (1995) (16)
How does T antigen transform cells? (1977) (16)
Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells. (1988) (15)
Filling the mosaic of p53 actions: p53 represses RHAMM expression (2008) (14)
Assaying microRNA loss-of-function phenotypes in mammalian cells: Emerging tools and their potential therapeutic utility (2009) (14)
In Retrospect: The chromosome trail (2008) (13)
Is metastasis predetermined? (2007) (13)
Judah Folkman (1933-2008) (2008) (13)
Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice (2020) (12)
The molecular basis of retinoblastomas. (1989) (12)
Chapter 2 : Hallmarks of Cancer : An Organizing Principle for Cancer Medicine (2015) (11)
Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells (2015) (11)
PRELIMINARY EVIDENCE OF AN ASSOCIATION BETWEEN AN ACTIVATED CELLULAR TRANSFORMING GENE AND A TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN11This work was supported by grants from the NIH. (1982) (11)
Using maths to tackle cancer (2007) (11)
Metastasis suppression: a role of the Dice(r) (2010) (10)
Regulation of expression of the integrated retrovirus genome. (1981) (10)
12 Oncogenes and Multistep Carcinogenesis (1989) (10)
The RNA metabolism of nucleoli and mitochondria in mammalian cells. (1969) (10)
The Hallmarks of Cancer Review evolve progressively from normalcy via a series of pre - (1999) (10)
The genetic bases of cancer. Lucy Wortham James lecture. (1990) (10)
Health for life. Your lifestyle, your genes, and cancer. (2008) (9)
Oncogenes of human tumor cells (1982) (9)
Negative growth controls and carcinogenesis (1990) (8)
A Breast Cancer Stem Cell Niche Supported by Juxtacrine Signaling from Monocytes and Macrophages (2015) (8)
Mapping of SV40 mRNA species on the viral genome. (1975) (8)
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation (2002) (8)
An EMT–primary cilium–GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis (2020) (8)
Cancer Biology & Therapy: The Road Ahead (2002) (7)
Oncogenes and tumor progression. (1986) (7)
Transforming genes of tumor cells. (1983) (7)
There are two large questions (1991) (7)
Author Correction: Guidelines and definitions for research on epithelial–mesenchymal transition (2021) (7)
A human Ki-ras oncogene encodes two transforming p21 proteins (1986) (7)
Abstract 5544: Development of recombinant transcription factor proteins and antibodies for application in clinical immunoassays. (2013) (6)
Influence of p21ras on phosphatidylinositol turnover. (1988) (6)
2 Growth Factors and Oncogenes (1989) (6)
Activated oncogenes in Burkitt's lymphoma. (1984) (6)
A chromosomal expression vector for Escherichia coli based on the bacteriophage Mu. (1993) (6)
Metastasis: objections to the same-gene model (2002) (6)
The SUMO guards for SNAIL (2017) (5)
Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages (2015) (5)
How Cancer Arises An explosion of research is uncovering the long-hidden molecular underpinnings of cancer — and suggesting new therapies by (5)
Anti-oncogenes and the negative regulation of cell growth. (1988) (5)
Cooperation between cellular oncogenes in the transformation of primary rat embryo fibroblasts. (1985) (5)
L'apparition des cancers (1996) (5)
Syndecan-mediated ligation of ECM proteins triggers proliferative arrest of disseminated tumor cells. (2019) (5)
Retraction Notice to: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (2015) (5)
Poised chromatin at the ZEB1 promoter enables cell plasticity and enhances tumorigenicity (2014) (5)
Rules governing the creation of human tumor cells (2001) (4)
encodes a netrin receptor (1997) (4)
Generation of stem-like cells via EMT; a new twist in cancer initiation and progression (2009) (4)
Oncogenes and the molecular basis of cancer. (1984) (4)
You can't get there from here: the tortuous road to basic research (1994) (4)
Development of monoclonal antibodies reactive with the product of the neu oncogene. (1986) (4)
1 – Cancer: A Genetic Disorder (2014) (4)
Inadvertent Cancer Research (2004) (4)
Robert Weinberg (2011) (4)
Erratum to Species- and Cell Type-Specific Requirements for Cellular Transformation [Cancer Cell 6, (2004) 171-183] (2013) (3)
The Roots of Human Cancer (1988) (3)
Otto Warburg Medal: Mechanisms of Cancer Cell Invasion and Metastasis (2007) (3)
Transforming growth factor ,B effects on expression of G1 cyclins and cyclin-dependent protein kinases (2005) (3)
Targets for specific therapies in leukemia. (1995) (3)
Integration and possible transduction by retroviruses. (1979) (2)
1035 DCC (Deleted in colorectal cancer) encodes a netrin receptor (1997) (2)
Retraction: Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. (2015) (2)
Hunting the elusive oncogene: a stroke of good luck (2011) (2)
Organization of murine sarcoma virus genomes. (1980) (2)
Growth suppression by p 16 ink requires functional retinoblastoma protein ( cell cycle / cyclin D / cyclin-dependent kinases ) (2005) (2)
Ras oncogenes in human tumours: identification, mechanism of activation and cooperative role in transformation. (1985) (2)
Identification of a Protein Interacting with ras -p21- by Chemical Cross-Linking (1989) (1)
The oncogene of a human bladder carcinoma. (1983) (1)
Abstract LB-194: Restoration of miR-31 function in already-established metastases elicits an anti-metastatic therapeutic responsein vivo. (2010) (1)
Guidelines and definitions for research on epithelial–mesenchymal transition (2020) (1)
To sequence or not to sequence. (1988) (1)
232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade (2020) (1)
Anything and everything on viral oncogenesis Viral oncology. G. Klein, ed. New York: Raven Press. (1980). 842 pp. $85.00 (1980) (1)
How TP53 (almost) became an oncogene (2019) (1)
ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells. (2022) (1)
MMD scaffolds ACSL4 and MBOAT7 to promote polyunsaturated phospholipid synthesis and susceptibility to ferroptosis (2022) (1)
Cellular Oncogenes and Multistep Carcinogenesis (2019) (1)
Generation of Breast Cancer Stem Cells by the EMT (2009) (1)
Confidentiality vs. Mentor Responsibilities: A Conflict of Obligations (1999) (1)
Abstract A82: Direct and indirect regulators of epithelial-to-mesenchymal transition mediated immunosuppression in breast carcinomas (2020) (1)
Running Title : Inflammation triggers escape from latency 1 TITLE : Inflammation triggers Zeb 1-dependent escape from tumor latency (2016) (1)
Correction for Bernards et al., Structure and Expression of the Murine Retinoblastoma Gene and Characterization of its Encoded Protein, PNAS 1989 86:6474-6478 (2006) (1)
Bengt Westermark and our current understanding of tumor pathogenesis (2012) (1)
All You Need Is Mentorship (2016) (1)
The human genome sequence: what will it do for us? (1988) (1)
Stem Cells Dispensable for Proliferation of Embryonic Immediate-Early Gene Activation yet Is Serum Response Factor Is Required for (2001) (1)
Chapter 1 – Cancer: A Genetic Disorder (2008) (1)
Perspectives in CancerResearch Oncogenes, Antioncogenes, and the Molecular Bases of Multistep Carcinogenesis1 (1989) (1)
Leveraging immunochemotherapy for treating pancreatic cancer (2021) (1)
Oncogenes and tumor suppressor genes. (1988) (0)
Abstract C27: Activation of PKA induces a mesenchymal-to-epithelial transition and epigenetic reprogramming-mediated loss of tumor initiating ability (2015) (0)
p100 "new" human protein metallic and use of this protein for the detection of neoplastic preneoplasmatischen- or in humans (1989) (0)
Polymer-Modified Concrete ACI 548 . 3 R-03 Reported by ACI Committee 548 (2003) (0)
TRANSFECTION OF MOLONEY MuLV DNA (1976) (0)
Comprar The Biology of Cancer | Robert A. Weinberg | 9780815342205 | Garland Science (2013) (0)
Genetics of tumor metastasis 2 (2015) (0)
Title An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer (2018) (0)
License and neglect The nature and organization of retroviral genes in animal cells. Virology monographs,17. By D. R. Strayer and D. H. Gillespie. Wien, New York: Springer-Verlag. (1980). 117 pp. $39.80 (1980) (0)
cDNA sequencing : an alternative strategy for the human genome project (1990) (0)
IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization (2018) (0)
James Lecture (2004) (0)
Abstract PR010: Potentiating the efficacy of immune checkpoint blockade by targeting the epithelial-to-mesenchymal transition (EMT) in breast carcinomas (2021) (0)
Invasion, metastasis and stem cells (2009) (0)
A method for producing an antibody, which is capable of determining the presence of a human oncogene. (1983) (0)
INITIATION OF MOLECULAR CLONING OF A TRANSFORMING ALLELE OF CHEMICALLY TRANSFORMED MOUSE CELLS1 (1980) (0)
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer (2018) (0)
How Does T Antigen Transform Cells? Review (1977) (0)
Letter from Robert A. Weinberg, Federation of American Scientists to Joshua Lederberg (1990) (0)
Abstract 863: Neuronal splicing regulatory factors are upregulated in models of epithelial-mesenchymal transition (2017) (0)
Abstract PR12: Genetic aberrations dictate distinct tumor immune landscape and chemosensitivity in HGSOC (2020) (0)
The Successful Side Business (1997) (0)
Abstract B61: The genotype of serous carcinomas shapes the tumor microenvironment and modulates responses to targeted and immune checkpoint therapies (2020) (0)
TITLE : Generation of Breast Cancer Stem Cells by the EMT PRINCIPAL INVESTIGATOR : (2010) (0)
Abstract PR13: Understanding the systemic interactions between primary tumors and disseminated tumor initiating cells (2016) (0)
Cell cycle-specific association of E2F with the p 130 E 1A-binding protein (2007) (0)
Remembering a pioneer in biotechnology (2021) (0)
Control of the Mammary Cell Cycle Clock by Estrogen and Progesterone (1997) (0)
Towards an animal model for retinoblastoma (1989) (0)
Histopathology indicates multi-step tumor progression colon head and neck cervix lung (0)
The catalytic subunit of yeast telomerase ( telomeres y reverse transcriptase (1997) (0)
Analysis of the neu-Encoded Protein and Its Mechanism of Oncogenic Activation (1986) (0)
Abstract B150: Juxtacrine signaling between the tumor-associated macrophages and the breast cancer stem cells contribute to the cancer stem cell niche by inducing a cytokine signaling network (2016) (0)
Abstract C75: Granulin‐expressing bone marrow cells promote the outgrowth of indolent tumors (2009) (0)
[Genetic Analyses of Salivary Gland Tumors] DISSERTATION (2009) (0)
Abstract PR1: Development of new immune therapy combinations for ovarian cancer using genetically defined organoid platform (2020) (0)
David M. Livingston (1941-2021). (2021) (0)
Scientific Research Center of Dersim and Koçgiri (2009) (0)
10 11 Patterned Multi-site Stimulation in Conjunction with Multi-site Calcium imaging : a new experimental system for investigating function and plasticity in neuronal networks (2010) (0)
Mono clonal antibodies reactive with a 185 kilodalton phospho protein associated with the transforming genes of several rat neuro blastomas (1984) (0)
Abstract P2-04-03: Epigenomic analysis of cancer stem cell (CSC)-enriched triple-negative breast cancer (TNBC) populations reveals gene regulatory circuitry and novel tumor cell vulnerabilities (2018) (0)
21st Annual McGill Biomedical Graduate Conference (AMBGC) (2021) (0)
Oncogenesis as central determinants of carcinogenesis (1984) (0)
Cellular Oncogenes and the Pathogenesis of Cancer (1984) (0)
There are two large questions. [Human Genome Project] (1991) (0)
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters (1986) (0)
Creationofhumantumourcells withde ® nedgenetic elements (1999) (0)
Letter from Robert A. Weinberg, Whitehead Institute to Joshua Lederberg (1989) (0)
Cellular oncogene activation (immunology series vol. 41): edited by George Klein, Marcel Dekker, 1988. $132.00 (xv + 396 pages) ISBN 0 8247 7983 5 (1989) (0)
Contribution of Bone Marrow-Derived Cells to the Tumor Stroma in Human Breast Cancer (2003) (0)
European Association for Cancer Research (2010) (0)
2ND STEM CELL SYMPOSIUM Cancer Stem Cells (2014) (0)
A method for the determination of infections caused by oncogenes cancer. (1983) (0)
Abstract PR04: The genomic architecture of serous carcinomas shapes the tumor microenvironment and modulates responses to targeted and immunotherapies (2019) (0)
Abstract 5020: A genome-scale ORF screen reveals an alternative splicing program that regulates mesenchymal and stem-like cell states in breast cancer (2017) (0)
The Discovery of ras and Its Biological Importance (1993) (0)
Pondering a Possible Retraction Infraction (2006) (0)
Abstract SY20-04: Mechanisms of malignant progression (2014) (0)
Abstract A36: Genome-scale ORF screening to identify modulators of the epithelial-to-mesenchymal transition (2017) (0)
Perspectivesin CancerResearch Oncogenes , Antioncogenes , and the Molecular Bases of Multistep Carcinogenesis 1 (2006) (0)
Cellular Brake Pad Inspection (2001) (0)
Abstract #5666: Systemic instigation of stromal desmoplasia and indolent tumor outgrowth via activation of granulin-expressing Sca1+/cKit- bone marrow cells (2009) (0)
Receptor type III TGF-beta, cDNA encoding it and its uses. (1992) (0)
Letter from Robert A. Weinberg, Massachusetts Institute of Technology Center for Cancer Research to Harold Varmus (1974) (0)
Abstract 1497: Inducing a mesenchymal-to-epithelial transition for the targeting of cancer stem cells. (2013) (0)
Abstract CN06-01: Cancer stem cells and the EMT. (2013) (0)
Breast Cancer Stem Cells and the Epithelial-Mesenchymal Transition. (2009) (0)
EMT, cell plasticity and metastasis (2016) (0)
Profiling extracellular vesicles in circulation enables the early detection of ovarian cancer (2023) (0)
George Khoury (1943–1987) (1987) (0)
Abstract 4320: Ovarian cancer persister cells are characterized by enhanced ER stress gene expression correlating with poor survival (2020) (0)
Mechanisms of malignant progression (2008) (0)
Abstract B25: Inhibition of autocrine signaling as a strategy to target tumor-initiating breast cancer cells (2013) (0)
Abstract P4-04-02: Epigenomic analysis of cancer stem cells (CSCs) from triple-negative breast cancer (TNBC) reveals p63 and p73 as core metastasis drivers (2020) (0)
HumanColonCarcinoma Ki-ras2 Oncogene andItsCorresponding Proto-Oncogene (1984) (0)
The impact of molecular biology on understanding of the human disease process. (1989) (0)
Interview: Oncogenes (0)
Progress in Cloning the Transforming Gene from Chemically-Transformed Mouse Cells (1980) (0)
SimianVirus40Transcription inProductively Infected and Transformed Cells (1974) (0)
Plasticity of ether lipids promotes ferroptosis susceptibility and evasion (2020) (0)
7.012 Introduction to Biology, Fall 2001 (2001) (0)
Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors (2022) (0)
Author response: An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer (2018) (0)
Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) (0)
Abstract PR05: Development of new immune therapy combinations for ovarian cancer using genetically defined organoid platform (2019) (0)
The dark side of the genome project (1991) (0)
Table of Contents (1986) (0)
Jessie Transformation Region Elements Necessary for Human Cell Enumeration of the Simian Virus 40 Early (2002) (0)
Abstract IA-21: Malignant progression and the stem‐cell state (2009) (0)
Retroviruses and human disease. (1983) (0)
Introduction to Biology (2004) (0)
Abstract IA26: Regulation of epithelial versus mesenchymal polarity and malignant progression (2016) (0)
FOXC2, Goosecoid, SIP1, Slug, Snail and Twist Induce EMT in Human Breast Cancer Cell Lines Through a Regulatory Network (2005) (0)
Abstract PR05: Loss of PRC2 or KMT2D-COMPASS generates two quasi-mesenchymal cell states with distinct metastatic abilities (2020) (0)
Linking EMT programmes to normal and neoplastic epithelial stem cells (2021) (0)
The transformation-associated cellular p53 protein (advances in viral oncology, vol. 2): edited by George Klein, Raven Press, New York, 1982. $39.68 (xii + 180 pages) ISBN 0 890 04857 6 (1983) (0)
ATTEMPTS AT THE MOLECULAR CLONING OF A TRANSFORMING ALLELE FROM CHEMICALLY TRANSFORMED MOUSE CELLS (1980) (0)
TITLE: Identification of Putative Metastasis Suppressor MicroRNA in Human Breast Cancer (2009) (0)
Abstract LB-108: Formation and maintenance of mesenchymal and stem-cell states in the breast by paracrine and autocrine signals (2011) (0)
Book Review:Oncogenes and Tumor Suppressor Genes. F. Macdonald, C. H. J. Ford (1993) (0)
Epigenetic coding of EMT regulators as diagnostic targets for breast cancer (2015) (0)
The Missing Data Points (1997) (0)
Abstract A29: The genomic architecture of serous carcinomas shapes the tumor microenvironment and modulates responses to targeted and immunotherapies (2020) (0)
Tyrosine kinases to Ras (1993) (0)
Training and Supervising Field Workers (2009) (0)
Abstract SY23-02: Actions of the EMT Program in fostering malignant progression (2019) (0)

This paper list is powered by the following services:

Other Resources About Robert Weinberg

What Schools Are Affiliated With Robert Weinberg ?

Robert Weinberg is affiliated with the following schools:

Robert Weinberg 's Academic­Influence.com Rankings